London, June 17: With just one day to go, the second edition of the London Biotechnology Show (LBS) is set to return to ExCeL London on 18–19 June, uniting one of the most influential communities in the global biotech ecosystem. This premier event promises a showcase of cutting-edge science,
Wahid Awad, Founder and CEO of Rosetta Omics, joined Muhammad Younis for an insightful discussion on the future of precision oncology. He highlighted the challenges of moving beyond standard treatments and the promise of AI, multiomics, and spatial data in delivering personalised cancer care. Wahid shared how Rosetta Omics is
United kingdom, On April 23: MHRA Grants Approval to First-Ever UK Treatment for Friedreich’s Ataxia The Medicines and Healthcare products Regulatory Agency (MHRA) has approved omaveloxolone (sold under the name Skyclarys), making it the first licensed therapy in the UK for patients aged 16 and over with Friedreich’s
United Kingdom, Apr 21, 2024: A significant advancement in surgical technology has been introduced at HCA Healthcare UK, as London Bridge Hospital becomes the first in the nation to offer robotic-assisted procedures using the state-of-the-art da Vinci Single Port (SP) system. Developed by Intuitive, this innovative system allows surgeons to
United Kingdom, 11 April 2025: The UK has begun a 12-month rollout of the most significant reform to its clinical trial regulations in over two decades. Signed into law, the new framework aims to enhance patient safety, speed up approvals, and make the UK a more attractive location for medical